CES1 (carboxylesterase 1)

2003-06-01  

Identity

HGNC
LOCATION
16q12.2
LOCUSID
ALIAS
ACAT,CE-1,CEH,CES2,HMSE,HMSE1,PCE-1,REH,SES1,TGH,hCE-1
FUSION GENES

Other Information

Locus ID:

NCBI: 1066
MIM: 114835
HGNC: 1863
Ensembl: ENSG00000198848

Variants:

dbSNP: 1066
ClinVar: 1066
TCGA: ENSG00000198848
COSMIC: CES1

RNA/Proteins

Gene IDTranscript IDUniprot
ENSG00000198848ENST00000360526P23141
ENSG00000198848ENST00000361503P23141
ENSG00000198848ENST00000422046P23141
ENSG00000198848ENST00000563241H3BQV8
ENSG00000198848ENST00000565568H3BQR4
ENSG00000198848ENST00000569260H3BSU0

Expression (GTEx)

0
50
100
150
200
250
300
350
400
450

Pathways

PathwaySourceExternal ID
Drug metabolism - other enzymesKEGGko00983
Drug metabolism - other enzymesKEGGhsa00983
Metabolic pathwaysKEGGhsa01100
MetabolismREACTOMER-HSA-1430728
Biological oxidationsREACTOMER-HSA-211859
Phase 1 - Functionalization of compoundsREACTOMER-HSA-211945

Protein levels (Protein atlas)

Not detected
Low
Medium
High

PharmGKB

Entity IDNameTypeEvidenceAssociationPKPDPMIDs
PA164748728mycophenolic acidChemicalPathwayassociated24220207
PA165108401Acute coronary syndromeDiseaseClinicalAnnotationassociatedPD
PA165110351DabigatranChemicalClinicalAnnotation, VariantAnnotationassociatedPKPD23467860, 27261537
PA165110775SN-38ChemicalPathwayassociated
PA1661312902-oxo-clopidogrelChemicalVariantAnnotationassociated23275066
PA443459Atrial FibrillationDiseaseClinicalAnnotation, VariantAnnotationassociatedPKPD23467860, 27261537
PA443672Ischemic Attack, TransientDiseaseClinicalAnnotationassociatedPD27450232
PA443783Constriction, PathologicDiseaseClinicalAnnotationassociatedPD27450232
PA443937Drug ToxicityDiseaseClinicalAnnotationassociatedPD28139840
PA447054StrokeDiseaseClinicalAnnotationassociatedPD27450232
PA447197Attention Deficit Disorder with HyperactivityDiseaseClinicalAnnotationassociatedPKPD19733552
PA448771capecitabineChemicalClinicalAnnotationassociatedPD28139840
PA449053clopidogrelChemicalClinicalAnnotation, MultilinkAnnotation, VariantAnnotationassociatedPKPD23275066, 24535487, 25704243, 27450232
PA449456enalaprilChemicalClinicalAnnotation, MultilinkAnnotationassociatedPK25919042
PA450085irinotecanChemicalPathwayassociated
PA450464methylphenidateChemicalClinicalAnnotation, VariantAnnotationassociatedPKPD19733552
PA450566mycophenolate mofetilChemicalPathwayassociated24220207
PA450721oseltamivirChemicalClinicalAnnotation, MultilinkAnnotationambiguousPK22673926
PA451205quinaprilChemicalMultilinkAnnotationnot associated25919042
PA451737trandolaprilChemicalVariantAnnotationassociatedPK19185566
PA452619heroinChemicalClinicalAnnotation, VariantAnnotationassociatedPK31837295

References

Pubmed IDYearTitleCitations
378514032024High-Dose Methylphenidate and Carboxylesterase 1 Genetic Variability in Patients With Attention-Deficit/Hyperactivity Disorder: A Case Series.0
378514032024High-Dose Methylphenidate and Carboxylesterase 1 Genetic Variability in Patients With Attention-Deficit/Hyperactivity Disorder: A Case Series.0
364133572023Identification of regulatory variants of carboxylesterase 1 (CES1): A proof-of-concept study for the application of the Allele-Specific Protein Expression (ASPE) assay in identifying cis-acting regulatory genetic polymorphisms.2
373723712023The Distribution of the Genotypes of ABCB1 and CES1 Polymorphisms in Kazakhstani Patients with Atrial Fibrillation Treated with DOAC.2
364133572023Identification of regulatory variants of carboxylesterase 1 (CES1): A proof-of-concept study for the application of the Allele-Specific Protein Expression (ASPE) assay in identifying cis-acting regulatory genetic polymorphisms.2
373723712023The Distribution of the Genotypes of ABCB1 and CES1 Polymorphisms in Kazakhstani Patients with Atrial Fibrillation Treated with DOAC.2
346330412022Carboxylesterase-1 Assisted Targeting of HDAC Inhibitors to Mononuclear Myeloid Cells in Inflammatory Bowel Disease.7
346970822022Transcriptional Regulation of Carboxylesterase 1 in Human Liver: Role of the Nuclear Receptor Subfamily 1 Group H Member 3 and Its Splice Isoforms.1
354597392022Adipose tissue-specific ablation of Ces1d causes metabolic dysregulation in mice.11
365534922022The Influence of Structural Variants of the CES1 Gene on the Pharmacokinetics of Enalapril, Presumably Due to Linkage Disequilibrium with the Intronic rs2244613.1
346330412022Carboxylesterase-1 Assisted Targeting of HDAC Inhibitors to Mononuclear Myeloid Cells in Inflammatory Bowel Disease.7
346970822022Transcriptional Regulation of Carboxylesterase 1 in Human Liver: Role of the Nuclear Receptor Subfamily 1 Group H Member 3 and Its Splice Isoforms.1
354597392022Adipose tissue-specific ablation of Ces1d causes metabolic dysregulation in mice.11
365534922022The Influence of Structural Variants of the CES1 Gene on the Pharmacokinetics of Enalapril, Presumably Due to Linkage Disequilibrium with the Intronic rs2244613.1
337918122021Clock gene Bmal1 controls diurnal rhythms in expression and activity of intestinal carboxylesterase 1.3

Citation

Dessen P

CES1 (carboxylesterase 1)

Atlas Genet Cytogenet Oncol Haematol. 2003-06-01

Online version: http://atlasgeneticsoncology.org/gene/40060